No Data
December 5th [Today's Investment Strategy]
[FISCO Selected Stock] [Material Stock] Japan Sogotech Group <7814> 445 yen (12/4) Engaged in printing, sales promotion, and original goods development. Announced the implementation of a share buyback of up to 0.6 million shares, equivalent to 1.27% of the issued shares, with a limit of 0.267 billion yen. On December 5, entrustment of repurchases will be made in the Tokyo Stock Exchange's off-auction own-share purchase trading system (ToSTNeT-3). As of December 4, 24, the company's shareholding of its own shares was 3.91 million 6240 shares. [Emerging Market
Pay attention to Keeper Technology and V-Cube.
In the U.S. stock market on the 4th, the Dow Jones Industrial Average rose 308.51 points to 45,014.04, the Nasdaq Composite Index rose 254.21 points to 19,735.12, and the Chicago Nikkei 225 futures in Osaka compared to daytime trading in Tokyo rose by 355 yen to 39,625 yen. The exchange rate is 1 dollar = 150.60-70 yen. In today's Tokyo market, World <3612> recovered from a 4.7% increase in November same-store sales compared to a 7.3% decrease in October, and the same-store sales of the Key Parla Lab operation in November increased by 9.3%.
KUMIAI Chemical, upward revision on 24/10, operating profit 11.5 billion yen, up from 10 billion yen.
Kumiai Chemical <4996> announced a revision of its financial estimates for the fiscal year ending October 2024. Revenue has been revised upwards from 155 billion yen to 161 billion yen, and operating profit has been adjusted from 10 billion yen to 11.5 billion yen. Due to an increase in shipments of agrochemicals for overseas markets, including the herbicide "Axive," in the agricultural and agrochemical business, it is expected that revenue and operating profit will increase compared to the revised estimates disclosed on June 4, 2024. 【Positive evaluation】 <4996> Kumiai Chemical Revision | 【Hold】 <4>
Daisan: Confirmation letter
Daisan: Semi-annual report - 51st period (2024/04/21 - 2025/04/20)
Daisan: Supplementary explanation of financial results for the 2nd quarter (interim period) of the fiscal year ending April 2025